Gabriel Schnetzler

626 total citations
28 papers, 446 citations indexed

About

Gabriel Schnetzler is a scholar working on Psychiatry and Mental health, Clinical Psychology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Gabriel Schnetzler has authored 28 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Psychiatry and Mental health, 8 papers in Clinical Psychology and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Gabriel Schnetzler's work include Sexual function and dysfunction studies (14 papers), Hormonal and reproductive studies (7 papers) and Sexuality, Behavior, and Technology (6 papers). Gabriel Schnetzler is often cited by papers focused on Sexual function and dysfunction studies (14 papers), Hormonal and reproductive studies (7 papers) and Sexuality, Behavior, and Technology (6 papers). Gabriel Schnetzler collaborates with scholars based in United States, United Kingdom and Switzerland. Gabriel Schnetzler's co-authors include Tara Symonds, Thomas M. Kündig, Gabriela Senti, Garry Jennings, C. Roland Wolf, Alma Fulurija, Michael Bachmann, Mike Kirby, Kelly H. Zou and Andrew G. Bushmakin and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Journal of Allergy and Clinical Immunology.

In The Last Decade

Gabriel Schnetzler

26 papers receiving 428 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gabriel Schnetzler United States	12	161	108	101	92	83	28	446
Paolo Mezzelani Italy	18	79 0.5×	93 0.9×	76 0.8×	126 1.4×	38 0.5×	49	907
B. Higgins United Kingdom	9	24 0.1×	216 2.0×	23 0.2×	94 1.0×	7 0.1×	12	484
Mohammad K. A. Basra United Kingdom	7	26 0.2×	37 0.3×	14 0.1×	17 0.2×	49 0.6×	11	397
Jin Young Choi South Korea	13	10 0.1×	9 0.1×	23 0.2×	32 0.3×	66 0.8×	36	437
Hyejin Park South Korea	13	11 0.1×	23 0.2×	44 0.4×	47 0.5×	17 0.2×	38	395
Maximilian Schielein Germany	13	28 0.2×	166 1.5×	3 0.0×	82 0.9×	34 0.4×	43	603
Anthony F. Porto United States	12	28 0.2×	13 0.1×	22 0.2×	96 1.0×	7 0.1×	29	559
J.C. Ruiz‐Carrascosa Spain	11	56 0.3×	21 0.2×	7 0.1×	27 0.3×	23 0.3×	33	399
Nancy Russell United States	14	21 0.1×	55 0.5×	5 0.0×	43 0.5×	93 1.1×	17	774
R. Rashmi India	9	49 0.3×	14 0.1×	3 0.0×	31 0.3×	52 0.6×	11	526

Countries citing papers authored by Gabriel Schnetzler

Since Specialization

Citations

This map shows the geographic impact of Gabriel Schnetzler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriel Schnetzler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriel Schnetzler more than expected).

Fields of papers citing papers by Gabriel Schnetzler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabriel Schnetzler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriel Schnetzler. The network helps show where Gabriel Schnetzler may publish in the future.

Co-authorship network of co-authors of Gabriel Schnetzler

This figure shows the co-authorship network connecting the top 25 collaborators of Gabriel Schnetzler. A scholar is included among the top collaborators of Gabriel Schnetzler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabriel Schnetzler. Gabriel Schnetzler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Renner, Florian, Jan Eckmann, Nicole A. Kratochwil, et al.. (2025). Abstract 5606: The novel brain-penetrant paradox breaker BRAF inhibitor RG6344 manifests exceptional activity in BRAF mutant colorectal cancers. Cancer Research. 85(8_Supplement_1). 5606–5606.

Vieito, María, Ignacio Matos, Oliver Bechter, et al.. (2025). Preliminary safety, pharmacokinetics, and clinical activity of RG6344 in patients with BRAF V600E-mutant metastatic colorectal cancer (mCRC).. Journal of Clinical Oncology. 43(16_suppl). 3542–3542.

Schnetzler, Gabriel, et al.. (2020). Vismodegib (ERIVEDGE) pregnancy prevention programme: assessment of risk awareness. Journal of Dermatological Treatment. 33(1). 466–472. 1 indexed citations

Schnetzler, Gabriel, et al.. (2019). Evolution to a Competency-Based Training Curriculum for Pharmaceutical Medicine Physicians in Switzerland. Frontiers in Pharmacology. 10. 164–164. 3 indexed citations

Theodore‐Oklota, Christina, et al.. (2016). Validation of a treatment satisfaction questionnaire in non-Hodgkin lymphoma: assessing the change from intravenous to subcutaneous administration of rituximab. Patient Preference and Adherence. Volume 10. 1767–1776. 12 indexed citations

Schlagenhauf, Patricia, Stephen Toovey, Gabriel Schnetzler, et al.. (2014). Malaria chemoprophylaxis regimens: A descriptive drug utilization study. Travel Medicine and Infectious Disease. 12(6). 718–725. 13 indexed citations

Toovey, Stephen, Keith Nieforth, Patrick F. Smith, et al.. (2014). Comparative benefit of malaria chemoprophylaxis modelled in United Kingdom travellers. Travel Medicine and Infectious Disease. 12(6). 726–732. 6 indexed citations

Arnet, Isabelle, et al.. (2014). Pharmaceutical quality of eight generics of ceftriaxone preparation for injection in Eastern Asia. Journal of Chemotherapy. 27(6). 337–342. 12 indexed citations

Simonelli, Chiara, et al.. (2012). Perceptions and opinions of men and women on a man's sexual confidence and its relationship to ED: results of the European Sexual Confidence Survey. International Journal of Impotence Research. 24(6). 234–241. 12 indexed citations

10.

Kirby, Mike, Gabriel Schnetzler, Kelly H. Zou, & Tara Symonds. (2011). Prevalence and detection rate of underlying disease in men with erectile dysfunction receiving phosphodiesterase type 5 inhibitors in the United Kingdom: a retrospective database study. International Journal of Clinical Practice. 65(7). 797–806. 12 indexed citations

11.

Symonds, Tara, et al.. (2011). A Feasibility Study Comparing Pharmacist and Physician Recommendations for Sildenafil Treatment. The Journal of Sexual Medicine. 8(5). 1463–1471. 6 indexed citations

12.

Symonds, Tara, Karin S. Coyne, Mary Kay Margolis, & Gabriel Schnetzler. (2011). The Ability of the General Male Public to Assess Their Suitability to Take 50-mg Sildenafil: An Assessment of the Comprehension of Patient Information Materials via Internet Survey. The Journal of Sexual Medicine. 8(7). 2038–2047. 4 indexed citations

13.

Schnetzler, Gabriel & Colin Hayward. (2011). Overview of Guidelines and Recommendations for the Planning, Conduct and Reporting of Company-Sponsored Observational, Noninterventional Studies in Europe. Pharmaceutical Medicine. 25(4). 235–244. 1 indexed citations

14.

Althof, Stanley E., Michael M. Berner, Irwin Goldstein, et al.. (2010). Interrelationship of Sildenafil Treatment Effects on the Physiological and Psychosocial Aspects of Erectile Dysfunction of Mixed or Organic Etiology. The Journal of Sexual Medicine. 7(9). 3170–3178. 25 indexed citations

15.

Morales, Antonio Martín, et al.. (2010). The EPIFARM Study: An Observational Study in 574 Community Pharmacies in Spain Characterizing Patient Profiles of Men Asking for Erectile Dysfunction Medication. The Journal of Sexual Medicine. 7(9). 3153–3160. 14 indexed citations

16.

Cappelleri, Joseph C., Andrew G. Bushmakin, Tara Symonds, & Gabriel Schnetzler. (2009). Scoring Correspondence in Outcomes Related to Erectile Dysfunction Treatment on a 4-Point Scale (SCORE-4). The Journal of Sexual Medicine. 6(3). 809–819. 26 indexed citations

17.

Moncada, Ignacio, J.M. Martínez-Jabaloyas, L. Rodríguez-Vela, et al.. (2009). Emotional Changes in Men Treated With Sildenafil Citrate for Erectile Dysfunction: A Double-Blind, Placebo-Controlled Clinical Trial. The Journal of Sexual Medicine. 6(12). 3469–3477. 26 indexed citations

18.

Buvat, Irène, Dimitrios Hatzichristou, Mario Maggi, et al.. (2008). Efficacy, tolerability and satisfaction with sildenafil citrate 100‐mg titration compared with continued 50‐mg dose treatment in men with erectile dysfunction. British Journal of Urology. 102(11). 1645–1650. 9 indexed citations

19.

Kündig, Thomas M., Gabriela Senti, Gabriel Schnetzler, et al.. (2006). Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults. Journal of Allergy and Clinical Immunology. 117(6). 1470–1476. 164 indexed citations

20.

Daigle, Isabelle, Beate Rückert, Gabriel Schnetzler, & Hans‐Uwe Simon. (2000). Induction of the IL-10 gene via the Fas receptor in monocytes - an anti-inflammatory mechanism in the absence of apoptosis. European Journal of Immunology. 30(10). 2991–2997. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact